tetradecanoylphorbol acetate and Angina Pectoris

tetradecanoylphorbol acetate has been researched along with Angina Pectoris in 3 studies

Research

Studies (3)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (33.33)	18.2507
2000's	2 (66.67)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Beck-Oldach, K; Horowitz, JD; Kennedy, JA; McFadden-Lewis, K; Murphy, GA; Wong, YW; Zhang, Y	1
Baj, Z; Czekalska, R; Janiszewska-Drobinska, B; Kosmider, M; Kowalski, J; Pasnik, J; Zeman, K	1
Hashimoto, H; Isshiki, T; Ochiai, M; Ono, Y; Sato, T; Takeshita, S; Terakura, M; Yokoyama, N	1

Trials

1 trial(s) available for tetradecanoylphorbol acetate and Angina Pectoris

Article	Year
Pentoxifylline decreases neutrophil respiratory bursts in patients with stable angina. Fundamental & clinical pharmacology, 1999, Volume: 13, Issue:2 Topics: Adult; Angina Pectoris; Angioplasty, Balloon, Coronary; Depression, Chemical; Female; Humans; In Vitro Techniques; Luminescent Measurements; Male; Middle Aged; N-Formylmethionine Leucyl-Phenylalanine; Neutrophils; Pentoxifylline; Respiratory Burst; Tetradecanoylphorbol Acetate; Tumor Necrosis Factor-alpha	1999

Article

Year

Pentoxifylline decreases neutrophil respiratory bursts in patients with stable angina.

Fundamental & clinical pharmacology, 1999, Volume: 13, Issue:2

Topics: Adult; Angina Pectoris; Angioplasty, Balloon, Coronary; Depression, Chemical; Female; Humans; In Vitro Techniques; Luminescent Measurements; Male; Middle Aged; N-Formylmethionine Leucyl-Phenylalanine; Neutrophils; Pentoxifylline; Respiratory Burst; Tetradecanoylphorbol Acetate; Tumor Necrosis Factor-alpha

1999

Other Studies

2 other study(ies) available for tetradecanoylphorbol acetate and Angina Pectoris

Article	Year
Effect of the anti-anginal agent, perhexiline, on neutrophil, valvular and vascular superoxide formation. European journal of pharmacology, 2006, Feb-15, Volume: 531, Issue:1-3 Topics: Angina Pectoris; Animals; Animals, Newborn; Aorta, Thoracic; Aortic Valve; Cardiovascular Agents; Cell Membrane; Cells, Cultured; Dose-Response Relationship, Drug; Enzyme Inhibitors; Female; Free Radical Scavengers; Humans; In Vitro Techniques; Luminescent Measurements; Male; N-Formylmethionine Leucyl-Phenylalanine; NADP; NADPH Oxidases; Neutrophils; Perhexiline; Rats; Rats, Wistar; Superoxides; Swine; Tetradecanoylphorbol Acetate	2006
Increased leukocyte activity as a predictor for flow-limiting coronary lesions in patients with angina pectoris. Atherosclerosis, 2001, Volume: 158, Issue:2 Topics: Angina Pectoris; Coronary Angiography; Coronary Circulation; Coronary Stenosis; Female; Humans; Luminescent Measurements; Luminol; Male; Middle Aged; Neutrophil Activation; Sensitivity and Specificity; Tetradecanoylphorbol Acetate	2001

Article

Year

Effect of the anti-anginal agent, perhexiline, on neutrophil, valvular and vascular superoxide formation.

European journal of pharmacology, 2006, Feb-15, Volume: 531, Issue:1-3

Topics: Angina Pectoris; Animals; Animals, Newborn; Aorta, Thoracic; Aortic Valve; Cardiovascular Agents; Cell Membrane; Cells, Cultured; Dose-Response Relationship, Drug; Enzyme Inhibitors; Female; Free Radical Scavengers; Humans; In Vitro Techniques; Luminescent Measurements; Male; N-Formylmethionine Leucyl-Phenylalanine; NADP; NADPH Oxidases; Neutrophils; Perhexiline; Rats; Rats, Wistar; Superoxides; Swine; Tetradecanoylphorbol Acetate

2006

Increased leukocyte activity as a predictor for flow-limiting coronary lesions in patients with angina pectoris.

Atherosclerosis, 2001, Volume: 158, Issue:2

Topics: Angina Pectoris; Coronary Angiography; Coronary Circulation; Coronary Stenosis; Female; Humans; Luminescent Measurements; Luminol; Male; Middle Aged; Neutrophil Activation; Sensitivity and Specificity; Tetradecanoylphorbol Acetate

2001